Ergoteles’s Boston Scientific BSX Stock Holding History

Ergoteles’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,262	Closed	-$1.64M	–	148
2023 Q2	$1.64M	Buy	+30,262	New	+$1.58M	0.08%	324
2022 Q4	–	Sell	-16,077	Closed	-$623K	–	1473
2022 Q3	$623K	Sell	16,077 -11,254	-41%	-$451K	0.02%	673
2022 Q2	$1.02M	Buy	27,331 +10,237	+60%	+$417K	0.03%	533
2022 Q1	$757K	Buy	+17,094	New	+$741K	0.03%	520
2021 Q3	–	Sell	-13,434	Closed	-$574K	–	1243
2021 Q2	$574K	Buy	+13,434	New	+$565K	0.01%	742

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ergoteles's BSX Position: Q3 2023 in Review

Ergoteles sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 30,262 shares — an estimated $1.64M sold.

Ergoteles first reported a position in BSX in Q2 2021 and held it in 5 quarters. The position peaked at $1.64M in Q2 2023. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

Ergoteles reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 30,262 Boston Scientific shares in Q3 2023, an estimated $1.64M.
Ergoteles first reported a position in Boston Scientific in Q2 2021 and held it in 5 quarters.
Ergoteles's Boston Scientific position peaked at $1.64M in Q2 2023.
1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.